相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Julien Fourcade et al.
CANCER RESEARCH (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
Moniek Heusinkveld et al.
JOURNAL OF IMMUNOLOGY (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy
Qian Huang et al.
NATURE MEDICINE (2011)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Inhibition of prostaglandin E2 signaling through the EP1 receptor does not affect prostacyclin production in human endothelial cells
Tatsuya Kaneshiro et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells
G. O'Callaghan et al.
BRITISH JOURNAL OF CANCER (2008)
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner
Sheraz Yaqub et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
COX-2 inhibitors and cardiovascular risk
Colin D. Funk et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma
Christoph Bergmann et al.
CANCER RESEARCH (2007)
EP1-4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease-specific mortality
Annika Gustafsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Inflammation and breast cancer - Cyclooxygenase/prostaglandin signaling and breast cancer
Louise R. Howe
BREAST CANCER RESEARCH (2007)
Targeting prostaglandin E EP receptors to inhibit metastasis
Amy M. Fulton et al.
CANCER RESEARCH (2006)
Cytotoxic T cells
Mads Hald Andersen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Addressing the Fas counterattack controversy:: Blocking Fas ligand expression suppresses tumor immune evasion of colon cancer in vivo
AE Ryan et al.
CANCER RESEARCH (2005)
Resazurin assay of radiation response in cultured cells
S Anoopkumar-Dukie et al.
BRITISH JOURNAL OF RADIOLOGY (2005)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist
N Niho et al.
CANCER SCIENCE (2005)
Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development
T Kawamori et al.
CARCINOGENESIS (2005)
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages
T Katakura et al.
JOURNAL OF IMMUNOLOGY (2004)
The Fas signalling pathway and its role in the pathogenesis of cancer
A Houston et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice
T Kitamura et al.
CANCER SCIENCE (2003)
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex
N Holler et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
T Kawamori et al.
CARCINOGENESIS (2001)
IL-9 stimulates release of chemotactic factors from human bronchial epithelial cells
FF Little et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases
VA Fadok et al.
JOURNAL OF IMMUNOLOGY (2001)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice
K Watanabe et al.
CANCER LETTERS (2000)
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
M Stolina et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
